Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Growing evidence of effectiveness is counterbalanced by inadequate regulation
Sales of herbal medicines are booming. This is
particularly true in the United States, where the market for herbal
supplements is now approaching $4bn a year. The fastest growth has been
recorded for St John's wort, a herbal antidepressant whose sales
increased in one year by 2800%.1 Faced with such figures
doctors are inclined to ask where the evidence is. Are there rigorous
trials to show that herbal treatments work?
Single studies are unlikely to convince sceptics, but an
increasing body of evidence is now emerging from systematic reviews and
meta-analyses of randomised clinical trials. These suggest that some
herbal medicines are efficacious. The increased demand for St John's
wort, for instance, was triggered by press reports of a meta-analysis
of 23 randomised trials of 1757 patients with mild or moderate
depression. The authors concluded that extracts of hypericum were
significantly more effective than placebo (odds ratio 2.67; 95%
confidence interval 1.78 to 4.01) and as effective as conventional
antidepressants (odds ratio 1.10; 93 to 1.31) in alleviating the
symptoms of mild to moderate depression.2 Since this
article was published, at least nine further randomised trials have
appeared, all of which confirm the efficacy of this herbal
antidepressant.3
Systematic analyses of other herbal medicines followed and drew
similarly positive conclusions. A review of all nine placebo controlled, double blind randomised trials of ginkgo biloba for dementia, covering 1497 patients, showed that ginkgo was more effective
than placebo in delaying the clinical course of dementia.4 A meta-analysis of 18 randomised controlled trials (2939 patients) of
saw palmetto as a symptomatic treatment for benign prostate hyperplasia
showed that it improved urological symptoms and flow measures
significantly more than placebo.5 Saw palmetto was as
effective as finasteride and had fewer adverse effects. A systematic review of horse chestnut seed extracts for chronic venous insufficiency included eight placebo controlled and five comparative randomised trials with a total of 1083 patients.6 All placebo
controlled trials were positive and all comparative trials indicated
equivalence with other active therapies. The effects included a
reduction in leg volume and leg circumference as well as symptomatic
improvements. In all, about 40 systematic reviews or meta-analyses of
herbal drugs are available today (a full list provided by the author is
available on the BMJ 's website).
With many of these herbal medicines we do not fully understand how they
work. Nor do we always know which component is pharmacologically active. For example, hypericin was originally thought to be the active
ingredient in St John's wort, but evidence is now accumulating that
hyperforin may be equally important.7 Similarly, we
assumed until recently that its mode of action was that of a monoamine oxidase inhibitor, but its actions may be due, at least partly, to
serotonin uptake inhibition.3
Even though herbal remedies may be effective, do their benefits
outweigh the risks? Most herbal remedies in the United Kingdom and
United States are sold as food supplements. Thus they evade regulation
of their quality and safety. The UK's minister for public health
recently pointed out that "the regime for unlicensed medicines does
not give systematic protection to the public against low quality and
unsafe unlicensed herbal remedies."8 Two recent British
cases of severe nephropathy caused by Chinese herbal tea administered
to treat eczema9 illustrate this. Huge variations exist in
the quality of herbal medicinal preparations. When, for example, German
commercial products of devil's claw were tested, an unacceptable
variability of quality was noted.10 Yet Germany is often
praised for the exemplary standard of quality control of herbal
medicines. A recent study of herbal creams in the United Kingdom showed
that 8 of 11 preparations contained undeclared dexamethasone at a mean
concentration of 456 mg/g.11
The possibility of herb-drug interactions is a further important With rationing looming in virtually all healthcare systems, the
question whether herbal medicines can save money is important. Not all
plant based medicines are cheap. A standard daily dose of St John's
wort, for instance, will cost more than that of a tricyclic
antidepressant. However, such comparisons are oversimplistic, particularly in view of the fact that St John's wort is associated with only about half the incidence of adverse effects of a conventional antidepressant.2
As more and more herbal medicines are being used by more and more
people, doctors should consider changing their often negative attitude
towards them. Doctors, pharmacists, and other healthcare professionals
need to be knowledgeable to advise their patients responsibly, and
there is an unquestionable need for reliable information on herbal
medicines, a demand that must be met adequately by undergraduate and
postgraduate education. Doctors also have to realise that detailed
questions about use of herbal drugs form an essential part of taking a
medical history. Finally, doctors should monitor the perceived benefits
and adverse effects of self prescribed herbal treatments consumed by
their patients and bear in mind the possibility of herb-drug
interactions. The minister for public health has emphasised the need
for better protection and information for the public on herbal
medicines,"8 and doctors should take an active part in
this process.
Department of Complementary Medicine, School of Postgraduate
Medicine and Health Sciences, University of Exeter, Exeter EX2 4NT
(E.Ernst{at}exeter.ac.uk )
and
under-researched
issue. On its own, for instance, ginseng has few
serious adverse effects. When combined with warfarin, its antiplatelet
activity might cause overanticoagulation.12 Many other
interactions between herbal remedies and synthetic drugs are
conceivable, even likely.13 This issue is destined to play
an increasingly important part in the debate about the safety of phytomedicines.
Footnotes
A full list of systematic
reviews of trials of herbal medicines appears on the BMJ's website
| 1. | Brevoort P. The booming US botanical market. A new overview. Herbalgram 1998; 44: 33-46. |
| 2. |
Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D.
St John's wort for depression: an overview and meta-analysis of randomised clinical trials.
BMJ
1996;
313:
253-258 |
| 3. | Stevinson C, Ernst E. Hypericum for depression: an update of the clinical evidence. Eur Neuropharmacol (in press). |
| 4. | Ernst E, Pittler MH. Ginkgo biloba for dementia: a systematic review of double-blind, placebo-controlled trials. Clin Drug Invest 1999; 17: 301-308. |
| 5. |
Wilt TJ, Iskani A, Stark G, McDonald R, Lan J, Murlow C.
Saw palmetto extracts for treatment of benign prostatic hyperplasia.
JAMA
1998;
280:
1604-1609 |
| 6. |
Pittler MH, Ernst E.
Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review.
Arch Dermatol
1998;
134:
1356-1360 |
| 7. | Müller WE, Singer A, Wonnemann M, Hafner U, Schäfer C. Hyperforin represents the neurotransmitter uptake inhibiting constituent of hypericum extract. Pharmacopsychiat 1998; 31(suppl): 16-21. |
| 8. | Jowell T. Herbal medicines. In: House of Commons official report (Hansard) , 1999 March 26;426-27. |
| 9. | Lord GM, Tagore R, Cook T, Gower P, Pusey CD. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354: 481-482[CrossRef][Medline]. |
| 10. | Chrubasik S, Sporner F, Wink M. Zum Wirkstoffgehalt in Arzneimitteln aus Hapargophytum procumbens. Forsch Komplementärmed 1996; 3: 57-63. |
| 11. |
Keane FM, Munn SE, du Vivier AWP, Taylor NF, Higgins EM.
Analysis of Chinese herbal creams prescribed for dermatological conditions.
BMJ
1999;
318:
563-564 |
| 12. |
Janetzky K, Morreale AP.
Probable interactions between warfarin and ginseng.
Am J Health Syst Pharm
1997;
54:
692-693 |
| 13. | Ernst E. Possible interactions between synthetic and herbal medicinal products. Part 1: a systematic review of the indirect evidence. Perfusion (in press). |
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+